[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368597-105":59,"doc-detail-368597-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pabpn1-as-a-pan-cancer-biomarker-prognostic-significance-and-association-with-tumor-immune-microenvironment","PABPN1 as a pan-cancer biomarker - prognostic significance and association with tumor immune microenvironment","","Study investigates poly(A) binding protein nuclear 1 (PABPN1) as a pan-cancer biomarker to predict prognosis and support immunotherapy. Analyses integrate TCGA and GEO datasets with multiple expression and survival tools, assessing prognostic effects and links to tumor immune checkpoint markers, tumor mutational burden, microsatellite instability, and neoantigens. The study further evaluates correlations with tumor-infiltrating immune cell marker genes in urogenital cancers, and verifies findings using cell experiments across T24, 5637, HLF, and MCF-7 lines. Results show higher PABPN1 in cancers versus paired normal tissues, with strong associations to immunological features and immune-response pathways, and decreased MRPS15 and GPx after PABPN1 downregulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pabpn1-as-a-pan-cancer-biomarker-prognostic-significance-and-association-with-tumor-immune-microenvironment/368597/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pabpn1-as-a-pan-cancer-biomarker-prognostic-significance-and-association-with-tumor-immune-microenvironment/368597.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of this study?","Question",{"text":112,"@type":113},"To evaluate PABPN1 as a potential pan-cancer biomarker for prognosis and immunotherapy relevance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were PABPN1 associations with prognosis and immune features assessed?",{"text":117,"@type":113},"PABPN1 expression was analyzed using multiple public databases, with prognostic effects evaluated by survival-related tools, and correlations tested against immune checkpoint markers, TMB, MSI, and neoantigens.",{"name":119,"@type":110,"acceptedAnswer":120},"What key results link PABPN1 to tumor immune microenvironment?",{"text":121,"@type":113},"PABPN1 expression is higher in cancers than paired normal tissues and shows strong associations with TMB, MSI, neoantigens, and tumor-infiltrated immune cell marker genes, particularly in urogenital cancers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368597,1790210888,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","TYPE Original Research PUBLISHED 18 June 2025  \nDOI 10.3389/fimmu.2025.1553527  \nOPEN ACCESS  \nEDITED BY  \nZong Sheng Guo,  \nUniversity at Buffalo, United States  \nREVIEWED BY  \nCao Jinlong,  \nLanzhou University Second Hospital, China Lingfeng He,  \nNanjing Normal University, China  \n*CORRESPONDENCE  \nYa-Ming Xi  \n [xiyaming02@163.com](xiyaming02@163.com)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 30 December 2024  \nACCEPTED 02 June 2025  \nPUBLISHED 18 June 2025  \nCITATION  \nLi H-X, Ma X-L, Ma W-b, Jia T-Y, Sun X-H, He X-X, Zhang L-l and Xi Y-M (2025) PABPN1 as a pan-cancer biomarker: prognostic signiﬁcance and association with tumor immune microenvironment.  \nFront. Immunol. 16:1553527 .  \ndoi: 10.3389/fimmu.2025.1553527  \nCOPYRIGHT  \n© 2025 Li, Ma, Ma, Jia, Sun, He, Zhang and Xi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nPABPN1 as a pan-cancer biomarker: prognostic signiﬁcance and association with tumor immune microenvironment  \nHong-Xing Li 1,2,3†, Xiao-Ling Ma 1,2†, Wang-bin Ma 4†,  \nTian-Yu Jia 1,2, Xiao-Hong Sun 1,3, Xiao-Xia He 1,2, Li-li Zhang 1,2 and Ya-Ming Xi 1,3*  \n1The First School of Clinical Medicine, Lanzhou University, Lanzhou, China, 2Clinical Medical Research Center for Reproductive Diseases of Gansu Province, Lanzhou, China, 3 Department of Hematology, The First Hospital of Lanzhou University, Lanzhou, China, 4 Department of General Surgery, Renmin Hospital of Wuhan University, Wuhan, China  \nObjective: This study aimed to investigate the role of poly(A) binding protein nuclear 1 (PABPN1) as a potential pan-cancer biomarker for prognosis and immunotherapy.  \nMethods: The original datasets were acquired from TCGA and GEO databases. PABPN1 expression analysis was conducted utilizing the Oncomine, TIMER, GEPIA, and BioGPS databases. Prognostic implications of PABPN1 were assessed through GEPIA, Kaplan-Meier plotter, and the PrognoScan database. Correlations between PABPN1 expression and immune checkpoints (ICP), tumor mutational burden (TMB), microsatellite instability (MSI), and neoantigens inhuman cancers were examined using the SangerBox database. Additionally, the association between PABPN1 and marker genes of tumor-inﬁltrated immune cells in urogenital cancers was conﬁrmed. Differential expression of PABPN1 inurogenital cancers with distinct clinical characteristics was assessed using the UALCAN database. Finally, experiments of T24, 5637, HLF and MCF-7 cells were performed to verify the above results.  \nResults: The expression of PABPN1 tended to be higher in human cancers compared to paired normal tissues . Its expression levels showed strong associations with TMB, MSI, and neoantigens . Additionally, signiﬁcant correlations existed between PABPN1 expression and tumor immuneinﬁltrated cells (TILs) in many human cancers, with marker genes of TILs showing signiﬁcant relationships with PABPN1 expression, particularly inurogenital cancers. The coexpression networks of PABPN1 were predominantly involved in the regulation of immune response, antigen processing, and presentation. After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased signiﬁcantly in T24, 5637 HLF and MCF-7 cells.  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nConclusion: PABPN1 was expected to be an important role element in cancer research, serving as a potential prognostic and immunological pancancer biomarker.  \nKEYWORDS  \nPABPN1, biomarker, prognostic, immune microenvironment, cancer  \nIntroduction  \nThe maturation pr","cbCaiecuXJaRWnaP","https://ap.wps.com/l/cbCaiecuXJaRWnaP","pdf",19972488,18,"English","# Objective\n# Methods\n## Bioinformatics analyses\n## Experimental validation\n# Results\n# Conclusion\n# Introduction\n## APA and PABPN1 in mRNA processing\n## Poly(A) tails and PABPN1 function","[{\"question\":\"What is the main objective of this study?\",\"answer\":\"To evaluate PABPN1 as a potential pan-cancer biomarker for prognosis and immunotherapy relevance.\"},{\"question\":\"How were PABPN1 associations with prognosis and immune features assessed?\",\"answer\":\"PABPN1 expression was analyzed using multiple public databases, with prognostic effects evaluated by survival-related tools, and correlations tested against immune checkpoint markers, TMB, MSI, and neoantigens.\"},{\"question\":\"What key results link PABPN1 to tumor immune microenvironment?\",\"answer\":\"PABPN1 expression is higher in cancers than paired normal tissues and shows strong associations with TMB, MSI, neoantigens, and tumor-infiltrated immune cell marker genes, particularly in urogenital cancers.\"}]","PABPN1 as a pan-cancer biomarker - prognostic significance and association with tumor immune microenvironment | PDF",1790177668,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/186510267e671d276a4883410a58af28.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd95c75611771b9ad709f0041bf713e1.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59e0279ffc4feaa7f34fdbcac5b03a94.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f153afe358a71f4fa4730e247dd6e9ee.webp",980,1385]